Drug Shortage Report for ISOPROTERENOL HYDROCHLORIDE INJECTION USP

Last updated on 2020-09-16 History
Report ID 124327
Drug Identification Number 00897639
Brand name ISOPROTERENOL HYDROCHLORIDE INJECTION USP
Common or Proper name ISOPROTERENOL HYDROCHLORIDE INJECTION USP
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) ISOPROTERENOL HYDROCHLORIDE
Strength(s) 0.2MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Packaging size 10 X 1mLa
ATC code C01CA
ATC description CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
Reason for shortage Shortage of an active ingredient.
Anticipated start date 2020-12-25
Actual start date
Estimated end date 2021-06-25
Actual end date
Shortage status Anticipated shortage
Updated date 2020-09-16
Company comments
Health Canada comments
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2020-09-16 French Compare
v2 2020-09-16 English Compare
v1 2020-09-16 English Compare